- Statement
     - Share
 

 

 
  STATEMENT OF DIRECTORS’ RESPONSIBILITIES IN RESPECT OF THE FINANCIAL STATEMENTS  
 

This statement, which should be read in conjunction with the Auditor’s Report, is made with a view to setting out the responsibilities of the Directors with respect to the financial statements.

 In accordance with the provisions of the Allied Matter Act, 1990, the Directors are responsible for the preparation of annual financial statements, which give a true and fair view of the financial position of the company and of the profit or loss for the financial year.

 The Directors responsibilities also include ensuring that:

a)       appropriate internal controls are established both to safeguard the assets of the company and to prevent and detect fraud and other irregularities;

 b)       the company keeps accounting records which disclose with reasonable accuracy the financial position of the company and which ensure that the financial statements comply with the requirements of the Companies and allied Matters Act 1990;

 c)       the company has used suitable accounting policies, consistently applied and supported by reasonable and prudent judgements and estimates, and that all applicable accounting standards have been followed.

 It is also the responsibility of the Directors to be satisfied that it is appropriate for the financial statements to be prepared on a going-concern basis unless it is presumed that the company will not continue in business.

 The Directors hereby present to the Members of the Company their report together with the audited financial statements for the year ended 31st December 2003.

 
 

Principal Activities

The company is principally engaged in the manufacture, marketing and distribution of a wide-range of pharmaceutical and Food products 

State of Affairs
In the opinion of the Directors, the state of the company’s affairs was satisfactory and there has been no material change since the date of the balance sheet.
 
Result

Turnover
Profit before taxation
Taxation
Profit after taxation
Dividend Proposed
Profit Retained transferred to General Reserve

N’000

1,537,467
125,953
(48,312)
77,641
(73,708)
3,933

 

Dividend

 The Board recommended a dividend of 20 kobo per share of 50 kobo, which amounts to N73,708,000 for financial year ended 31st December, 2003, subject to the deduction of withholding tax at the appropriate rate.

 

 

Evans Medical Plc

© Copyright 2006. All Rights Reserved